Cargando…
Fibrinogen Longmont: A Clinically Heterogeneous Dysfibrinogenemia with Discrepant Fibrinogen Results Influenced by Clot Detection Method and Reagent
Autores principales: | Leung, Becky, Beggs, Joanne, Mason, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786559/ https://www.ncbi.nlm.nih.gov/pubmed/35088022 http://dx.doi.org/10.1055/s-0041-1740644 |
Ejemplares similares
-
Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia
por: Martini, Francesca, et al.
Publicado: (2019) -
Fibrinogen BOE II: dysfibrinogenemia with bleeding and defective thrombin binding
por: Li, Yang, et al.
Publicado: (2023) -
Fibrinogen Yecheon: Congenital Dysfibrinogenemia with Gamma Methionine-310 to Threonine Substitution
por: Park, Eunkyung, et al.
Publicado: (2009) -
Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations
por: Cronjé, H. Toinét, et al.
Publicado: (2017) -
The association of alcohol with circulating total fibrinogen and plasma clot density is mediated by fibrinogen and FXIII genotypes
por: Rautenbach, Petro Hannie, et al.
Publicado: (2020)